Summary
The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late.
Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally
Source & full coverage: this summary is aggregated from MarketWatch, the original publisher. Read the complete report for full context, data and quotes.
Read the original report at MarketWatch →
